Isradipine缓释胶囊对高血压的疗效  

Efficacy and Safety of Slow Release Isradipine in Essential Hypertension

作　　者：徐成斌[1] 陈红[1] 吴彦[1] 郭丹杰[1] 赵狄[1] 

机构地区：[1]北京医科大学人民医院心内科

出　　处：《中国高血压杂志》1995年第2期147-149,共3页

摘　　要：Ｉｓｒａｄｉｐｉｎｅ缓释胶囊对高血压的疗效徐成斌，陈红，吴彦，郭丹杰，赵狄（北京医科大学人民医院心内科１０００４４）ＥｆｆｉｃａｃｙａｎｄＳａｆｅｔｙｏｆＳｌｏｗＲｅｌｅａｓｅＩｓｒａｄｉｐｉｎｅｉｎＥｓｓｅｎｔｉａｌＨｙｐｅｒｔｅｎｓｉｏｎ￥ＸｕＣ...The study is designed to evaluate the efficacy and safety of slow release oral isradipine in patients with essential hypertension. Twenty-eight patients(WHO criteria:Ⅰor Ⅱ stage) were treated with the calcium antagonist 5￣ 10 mg daily for four weeks.The results showed that the blood pressure was normalized or reduced in 24 (85. 7%) patients by the end of the fourth week. A full 24 hour blood pressure control was covered by the drug with a low incidence of side-effects such as headache and dizziness.It was concluded that slow release oral isradipinr is effective and safe. It can be used as first-line antihypertensive therapy.

关 键 词：高血压 降压药 ISRADIPINE 疗效 

分 类 号：R544.105[医药卫生—心血管疾病] R972.4[医药卫生—内科学]